TrialCancer chemotherapy and pharmacology2019

JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer.

Takayuki Yoshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.